BDPT (BioAdaptives) Total Operating Expense: $1.01 Mil (TTM As of Mar. 2026)


What is BioAdaptives Total Operating Expense?

BioAdaptives BDPT -47.50% Total Operating Expense is $1.01 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

BioAdaptives's Total Operating Expense for the three months ended in Mar. 2026 was $0.20 Mil. BioAdaptives's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $1.01 Mil.

BioAdaptives Total Operating Expense Related Terms

BioAdaptives Total Operating Expense Historical Data

* Premium members only.

The historical data trend for BioAdaptives's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioAdaptives Total Operating Expense Chart

BioAdaptives Annual Data
Trend Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.43 0.24 0.53 1.05

BioAdaptives Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.28 0.27 0.26 0.20

BioAdaptives Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $1.01 Mil mean?
BioAdaptives (BDPT) has a Total Operating Expense of $1.01 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on BioAdaptives and its competitors.
Is BioAdaptives' Total Operating Expense too high?
BioAdaptives' current Total Operating Expense is $1.01 Mil.
How does BioAdaptives' Total Operating Expense compare to NBND and BSFC?
BioAdaptives' Total Operating Expense of $1.01 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Consumer Packaged Goods company?
A good Total Operating Expense depends on the Consumer Packaged Goods industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on BioAdaptives and its competitors. BioAdaptives's current Total Operating Expense is $1.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioAdaptives stock overvalued right now?
BioAdaptives (BDPT) has a current Total Operating Expense of $1.01 Mil. The current Total Operating Expense is $1.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For BioAdaptives (BDPT), the current Total Operating Expense is $1.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioAdaptives Business Description

Address 2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.